======= AEBP1 =======
== Gene Information ==
* **Official Symbol**: AEBP1
* **Official Name**: AE binding protein 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=165|165]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8IUX7|Q8IUX7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=AEBP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AEBP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602981|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: May positively regulate MAP-kinase activity in adipocytes, leading to enhanced adipocyte proliferation and reduced adipocyte differentiation. May also positively regulate NF-kappa-B activity in macrophages by promoting the phosphorylation and subsequent degradation of I-kappa-B-alpha (NFKBIA), leading to enhanced macrophage inflammatory responsiveness. Can act as a transcriptional repressor. {ECO:0000250}.
|Peptidase M14|
|F5 F8 type C|
|regulation of collagen fibril organization|
|metallocarboxypeptidase activity|
|regulation of extracellular matrix organization|
|collagen binding|
|extracellular matrix structural constituent|
|protein processing|
|calmodulin binding|
|protein maturation|
|transcription corepressor activity|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|RNA polymerase II regulatory region sequence-specific DNA binding|
|regulation of supramolecular fiber organization|
|collagen-containing extracellular matrix|
|peptide metabolic process|
|cellular amide metabolic process|
|zinc ion binding|
|negative regulation of transcription by RNA polymerase II|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|proteolysis|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|extracellular space|
|negative regulation of gene expression|
|extracellular region|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.73|
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|1.71|
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|1.74|
|[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.82|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.539|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4265
* **Expression level (log2 read counts)**: 10.82
{{:chemogenomics:nalm6 dist.png?nolink |}}